Working... Menu

A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02939807
Recruitment Status : Recruiting
First Posted : October 20, 2016
Last Update Posted : May 30, 2019
National Cancer Institute (NCI)
Apogee Biotechnology Corporation
Information provided by (Responsible Party):
Medical University of South Carolina

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 30, 2023
  Estimated Study Completion Date : January 30, 2024